You are here

Article Text

Article menu

Download PDFPDF

Letters to the editor
Successful treatment of BALT lymphoma with combined chemotherapy
Free
  1. R Ali1,
  2. F Özkalemkaş1,
  3. T Özçelik1,
  4. V Özkocaman1,
  5. Ü Ozan1,
  6. A Tunali1,
  7. G Filiz2,
  8. O Gözü3
  1. 1Division of Hematology, Department of Internal Medicine, Uludağ University School of Medicine, Bursa, Turkey
  2. 2Department of Pathology, Uludağ University School of Medicine
  3. 3Department of Chest and Tuberculosis, Uludağ University School of Medicine
  1. Correspondence to:
    Associate Professor R Ali, Uludağ Üniversitesi Tip Fakültesi Hematoloji Bilim Dali, 16059 Görükle, Bursa, Turkey;
    ridvanali{at}uludag.edu.tr

https://doi.org/10.1136/thorax.58.4.368-b

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Primary pulmonary lymphoma arising from mucosa- or bronchus-associated lymphoid tissue (MALT or BALT) is a rare disease.1,2 We report a 30 year old man with low grade B cell BALT lymphoma who presented with a bulky mass in the lung and was treated successfully with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) combined chemotherapy.

    The patient was admitted with a dry cough, shortness of breath, back pain, and progressive infiltrates on chest radiographs. He had no …

    View Full Text